Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial
Thomas Pierre Walter, Julien Mazieres, Josiane Otto, et al.
BMC Public Health
|
January 20, 2026
Wastewater-based surveillance as a proactive public health tool: insights from SARS-CoV-2 monitoring in Kampala, Uganda (2023-2024)
Andrew Nsawotebba, Susan Nabadda, Isaac Ssewanyana, et al.
The Lancet. Oncology
|
March 28, 2024
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study
Stefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, et al.
The Lancet. Oncology
|
June 1, 2026
[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
Eric Baudin, Alice Durand, Amandine Beron, et al.
The Oncologist
|
February 12, 2020
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study)
Lola-Jade Palmieri, Laurent Mineur, David Tougeron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
, Josef Thaler, Richard Greil, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial
Thomas Pierre Walter, Julien Mazieres, Josiane Otto, et al.
BMC Public Health
|
January 20, 2026
Wastewater-based surveillance as a proactive public health tool: insights from SARS-CoV-2 monitoring in Kampala, Uganda (2023-2024)
Andrew Nsawotebba, Susan Nabadda, Isaac Ssewanyana, et al.
The Lancet. Oncology
|
March 28, 2024
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study
Stefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, et al.
The Lancet. Oncology
|
June 1, 2026
[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
Eric Baudin, Alice Durand, Amandine Beron, et al.
The Oncologist
|
February 12, 2020
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study)
Lola-Jade Palmieri, Laurent Mineur, David Tougeron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
, Josef Thaler, Richard Greil, et al.
Page
of 10